Clinical trial
Chemotherapy in Treating Patients With Advanced Non-small Cell Lung Cancer
NCT00003154 · Case Comprehensive Cancer Center, Other · Completed
Key facts
| NCT number | NCT00003154 |
|---|---|
| Title | Chemotherapy in Treating Patients With Advanced Non-small Cell Lung Cancer |
| Official title | Phase II Trial of 9-Aminocamptothecin (9-AC) Colloidal Dispersion (CD) 120-Hour Continuous Intravenous Infusion in Advanced Non-Small Cell Lung Cancer |
| Lead sponsor | Case Comprehensive Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug |
| Interventions | aminocamptothecin colloidal dispersion |
| Enrollment | 19 |
| Start date | Jan 1, 1998 |
| Primary completion | Apr 1, 2001 |
| Completion | Jun 1, 2001 |
| First posted | May 19, 2004 |
| Last update posted | Jun 10, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: